Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deals Of The Week Ponders Project Financing

Executive Summary

GSK has been out ahead of other big pharmas when it comes to investing in venture funds. Its deal with Avalon Ventures adds a new twist – investing as a partner rather than an LP and creating single-asset companies. Plus other notable deals involving Merck, AstraZeneca, Opko Health and more . . .

Advertisement

Related Content

GSK Will Be A Limited Partner In Sanderling Ventures’ New Fund
Backing New Index Fund, GSK, J&J Buy Into Asset-Centric Vision Of Biotech Future
Xalkori And The Art Of Modern Drug Development

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS055297

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel